Jinyu Bio-Technology CoSHSE:600201 +2.93%68 OCF Yield % is 2.20 as of Jul. 04, 2026, which is 35% below its 10-year median of 3.38. GuruFocus rates SHSE:600201 with a GF Score™ of 68/100 and a GF Value™ of ¥8.24 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,414 Biotechnology companies, Jinyu Bio-Technology Co ranks better than 84.51% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Jinyu Bio-Technology Co OCF Yield % Related Terms
Jinyu Bio-Technology Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600201 vs VRTX, REGN, ALNY: OCF Yield % Comparison
For the Biotechnology subindustry, Jinyu Bio-Technology Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jinyu Bio-Technology Co OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Jinyu Bio-Technology Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Jinyu Bio-Technology Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jinyu Bio-Technology Co (SHSE:600201) has a OCF Yield % of 2.20 as of Jul. 04, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Jinyu Bio-Technology Co and its competitors. This is 35% below median its historical median of 3.38. Over the past decade, Jinyu Bio-Technology Co's OCF Yield % has ranged from 1.42 to 6.56. According to the industry distribution chart, Jinyu Bio-Technology Co ranks #219 out of 1414 companies in the Biotechnology industry, placing it in the top 15.5%.
Is Jinyu Bio-Technology Co's OCF Yield % too high?
Jinyu Bio-Technology Co's current OCF Yield % of 2.20 is 35% below median its 10-year median of 3.38. Over the past 10 years, this metric has ranged from a low of 1.42 to a high of 6.56. Based on the distribution chart, Jinyu Bio-Technology Co ranks #219 out of 1414 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Jinyu Bio-Technology Co has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jinyu Bio-Technology Co's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Jinyu Bio-Technology Co ranks #219 out of 1414 companies for OCF Yield %. This places Jinyu Bio-Technology Co in the top 16% of its industry — outperforming the majority of peers. Historically, Jinyu Bio-Technology Co's own OCF Yield % has ranged from 1.42 to 6.56 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Jinyu Bio-Technology Co and its competitors. Jinyu Bio-Technology Co's current OCF Yield % is 2.20, which is 35% below median its own 10-year median of 3.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinyu Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Jinyu Bio-Technology Co (SHSE:600201) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥8.24, compared to a current price of ¥12.31 — trading 49.4% above its estimated fair value. The current OCF Yield % is 2.20, which is 35% below median its 10-year median of 3.38. Jinyu Bio-Technology Co's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Jinyu Bio-Technology Co (SHSE:600201), the current OCF Yield % is 2.20 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jinyu Bio-Technology Co (SHSE:600201) Overvalued in 2026?
Based on GuruFocus' analysis, Jinyu Bio-Technology Co stock appears to be overvalued.
The current stock price of ¥12.31 is trading 49.4% above its estimated GF Value™ of ¥8.24.
GuruFocus considers Jinyu Bio-Technology Co to be Significantly Overvalued.
Key valuation signals for SHSE:600201:
OCF Yield %: 2.20 (35% below median its 10-year median of 3.38)
GF Value™: ¥8.24 vs. price of ¥12.31 (49.4% above fair value)
No single metric tells the full story. See the SHSE:600201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jinyu Bio-Technology Co Ltd is engaged in the development and sales of veterinary biological products. Its products are used for pigs, poultry, pets, and ruminants.
68GF Score
Get the complete analysis for SHSE:600201
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600201 has been successfully added to your 
